Albuterol Sulfate Solution
Product Images NDC 81894-106

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate (NDC 81894-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Luoxin Aurovitas Pharma (chengdu) Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 % Change From Pre-dose Fev1 Intent-to-treat Population Day 1 (Albuterol Fig1)

A line graph titled 'Figure 1' showing the percentage change from pre-dose FEV1 in an intent-to-treat population on Day 1. The x-axis represents hours from pre-dose (0 to 6 hours), and the y-axis shows the percentage change (5% to 30%). Three treatment groups are depicted: albuterol 1.25 mg, albuterol 0.63 mg, and placebo, with albuterol treatments showing greater initial increases in FEV1 compared to placebo, followed by a decline over time.*

FDA Label Image

Carton Label (25 Vials)-1.25 mg/3 mL (Albuterol Fig10)

Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd., distributed by Aurobindo Pharma USA, Inc. The carton contains 5 pouches, each with five 3 mL sterile unit-dose vials for inhalation use only. The label includes dosage details, storage instructions, inactive ingredients, and pharmacist warning to dispense patient instructions from the package insert.*

FDA Label Image

Carton Label (30 Vials)-1.25 mg/3 mL (Albuterol Fig11)

Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd., distributed by Aurobindo Pharma USA, Inc. The carton contains 6 pouches, each with five 3 mL sterile unit-dose vials. Key visible information includes dosing strength, ingredients, storage conditions, and pharmacist instructions to detach the patient insert before dispensing.*

FDA Label Image

Figure 2 % Change From Pre-dose Fev1 Intent-to-treat Population Day 28 (Albuterol Fig2)

Line graph titled '% Change from Pre-Dose FEV1 Intent-to-Treat Population Day 28' showing the percentage change over 6 hours from pre-dose for three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The vertical axis represents % change, and the horizontal axis represents hours from pre-dose. The graph compares the effectiveness of the two albuterol doses versus placebo over time.*

FDA Label Image

Figure 1 (Albuterol Fig3)

An instructional illustration showing a hand operating a device with a mouthpiece and another hand holding a syringe-like instrument, seemingly preparing or administering an inhalation solution. The diagram emphasizes the interaction between the inhaler device and the liquid dispenser.*

FDA Label Image

Figure 2 (Albuterol Fig4)

An instructional illustration showing a hand holding a respiratory inhalation device and another hand inserting or removing a small, cylindrical component from the device. The image is labeled as Figure 2 and demonstrates part of the assembly or use process for the inhalation device.*

FDA Label Image

Figure 3, 4 (Albuterol Fig5)

Illustrations demonstrating the proper use of a respiratory inhalation device for administering albuterol sulfate solution. The images show a person positioning the mouthpiece for inhalation and pressing the device to release the medication into the lungs.*

FDA Label Image

Pouch Label (5 Vials)-0.63 mg/3 mL (Albuterol Fig6)

Label for Albuterol Sulfate Inhalation Solution 0.63 mg per 3 mL, a respiratory inhalation solution. The label indicates each unit dose vial contains 0.63 mg of albuterol equivalent to 0.75 mg of albuterol sulfate. The package contains five 3 mL sterile unit-dose vials. Distributed by Aurobindo Pharma USA, Inc. and manufactured by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.*

FDA Label Image

Carton Label (25 Vials)-0.63 mg/3 mL (Albuterol Fig7)

Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. The label states the product is a sterile unit-dose solution for inhalation only, with each vial containing 0.63 mg albuterol equivalent to 0.75 mg albuterol sulfate. The carton contains 5 pouches of five 3 mL vials each. Distributed by Aurobindo Pharma USA, Inc.*

FDA Label Image

Carton Label (30 Vials)-0.63 mg/3 mL (Albuterol Fig8)

Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg per 3 mL, sterile unit-dose vials for inhalation only. The carton contains 6 pouches of five 3 mL vials each. Distributed by Aurobindo Pharma USA, Inc. and manufactured by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. The label includes dosage details, storage conditions, and a barcode.*

FDA Label Image

Pouch Label (5 Vials)-1.25 mg/3 mL (Albuterol Fig9)

Label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. The label states each vial contains 1.25 mg albuterol equivalent to 1.5 mg albuterol sulfate, with five 3 mL sterile unit-dose vials per pouch. It includes storage instructions, usage directions for children ages 2 to 12, distributor details for Aurobindo Pharma USA, Inc., and a barcode.*

FDA Label Image

Albuterol-str (Albuterol Str)

Chemical structure of Albuterol Sulfate, depicting the molecular arrangement including hydroxyl groups, an aromatic ring, and a sulfate component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.